← Back to Search

WeCareAdvisor for Caregiver Support in Dementia

N/A
Waitlist Available
Led By Laura N Gitlin, PhD
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Caregiver has a visual impairment that prohibits interaction with the tool, and/or have a hearing impairment sufficient to prohibit telephone communication
Caregiver reports person living with dementia is not responsive to his/her environment (e.g., unable to understand short commands or recognize a person coming in/out of the room)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will help caregivers manage behavioral and psychological symptoms of dementia and reduce caregiver distress.

Who is the study for?
This trial is for primary caregivers who have been caring for someone with dementia for at least 6 months, can use a smartphone or computer with internet, and speak English. They must not be planning to move the person into long-term care soon, be in another similar study, or have severe visual/hearing impairments.
What is being tested?
The WeCareAdvisor online tool is being tested to see if it helps caregivers manage dementia-related behaviors better. Caregivers are split into groups: some get immediate prompts from the tool; others wait three months before starting. The intensity of these prompts varies between high and low.
What are the potential side effects?
Since this trial involves an online tool rather than medication, traditional side effects aren't expected. However, using the tool could potentially lead to increased screen time which might affect sleep patterns or cause eye strain.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My caregiver cannot see well enough to use certain tools or hear well enough for phone calls.
Select...
The person I care for with dementia does not respond to their surroundings.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Long-Term Change in Caregiver Confidence Managing Behavioral and Psychological Symptoms of Dementia
Long-Term Change in Person Living with Dementia- Frequency and Severity of Behaviors
Long-term Change in Caregiver Distress with Behaviors (3-Months)
+3 more
Secondary study objectives
Change in Person with Dementia's Medications
Long Term Change in Caregiver Wellbeing
Long Term Change in Caregiver- Negative Communications
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Waitlist Control after three months with high-Intensity promptsExperimental Treatment1 Intervention
After three months, caregivers will receive WeCareAdvisor and telephone and email prompts.
Group II: Waitlist Control after three months with Low-Intensity PromptsExperimental Treatment1 Intervention
After three months, caregivers will receive WeCareAdvisor and email prompts only.
Group III: Immediate treatment group with Low-Intensity PromptsExperimental Treatment1 Intervention
Caregivers will use the WeCareAdvisor tool for six months and receive email prompts only.
Group IV: Immediate treatment group with High-Intensity PromptsExperimental Treatment1 Intervention
Caregivers will use the WeCareAdvisor tool for six months and receive telephone and email prompts.

Find a Location

Who is running the clinical trial?

Drexel UniversityLead Sponsor
155 Previous Clinical Trials
47,960 Total Patients Enrolled
4 Trials studying Dementia
196 Patients Enrolled for Dementia
University of California, DavisOTHER
945 Previous Clinical Trials
4,755,878 Total Patients Enrolled
10 Trials studying Dementia
3,297 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,792 Previous Clinical Trials
28,191,632 Total Patients Enrolled
294 Trials studying Dementia
23,634,483 Patients Enrolled for Dementia
Johns Hopkins UniversityOTHER
2,332 Previous Clinical Trials
14,874,638 Total Patients Enrolled
33 Trials studying Dementia
81,476 Patients Enrolled for Dementia
Laura N Gitlin, PhDPrincipal InvestigatorDrexel University
Helen C Kales, MDPrincipal InvestigatorUniversity of California, Davis
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Dementia
100 Patients Enrolled for Dementia

Media Library

WeCareAdvisor Study Clinical Trial Eligibility Overview. Trial Name: NCT05012410 — N/A
Dementia Research Study Groups: Immediate treatment group with High-Intensity Prompts, Immediate treatment group with Low-Intensity Prompts, Waitlist Control after three months with Low-Intensity Prompts, Waitlist Control after three months with high-Intensity prompts
Dementia Clinical Trial 2023: WeCareAdvisor Study Highlights & Side Effects. Trial Name: NCT05012410 — N/A
WeCareAdvisor Study 2023 Treatment Timeline for Medical Study. Trial Name: NCT05012410 — N/A
~26 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top